KindlyMD’s NAKA Extends Selloff After Q3 Miss: Merger Accounting Spurs $59M Deal Loss, $22M Crypto Marks
KindlyMD missed its Q3 deadline, citing merger accounting complexity. NAKA fell to $0.55, down 25% in a week and 95% in six months, with expected $59M deal loss and $22M crypto markdowns.

Because Bitcoin
November 18, 2025
KindlyMD’s stock slide deepened after the company failed to file its third-quarter report on time, pointing to the accounting tangle from its merger with Nakamoto. Shares of the Bitcoin treasury operator, trading on Nasdaq as NAKA, fell about 10% Monday to $0.55, leaving the stock down roughly 25% in a week and more than 95% over six months.
The filing deadline for Q3—ended September 30—was November 14 for companies on the 45-day schedule. Instead of a 10-Q, KindlyMD told the SEC on Friday that merger-related accounting needs more time to ensure accuracy and completeness. Large accelerated filers get 40 days; all others, including KindlyMD, have 45.
What matters here isn’t the delay alone—it’s what the numbers suggest about the deal math. KindlyMD guided to a $59 million loss on its acquisition of Nakamoto, indicating the consideration exceeded the fair value of net assets received. Coupled with an expected $21.8 million positive change in the fair value of a contingent liability—often the mark-down of an earnout or similar obligation—the accounting implies the transaction’s initial assumptions are being recalibrated. When contingent consideration gets written down while the purchase price effectively produces a loss, investors often infer that performance expectations embedded in the deal have softened relative to the model used at signing.
Layer in the treasury marks. The company expects more than $22 million in unrealized losses on digital assets it still holds and $1.4 million in realized losses from sales, plus a $14.4 million loss on extinguishment of debt. In a volatile coin market, mark-to-market swings can overwhelm operating narratives, but the combination of realized losses and debt-related charges tends to read as balance sheet strain rather than merely paper volatility.
The strategic backdrop: KindlyMD merged earlier this year with Nakamoto, a Bitcoin treasury firm formerly known as Nakamoto Games. As part of that tie-up, Nakamoto founder David Bailey became CEO in August. He has posted on X about a new CEO taking over at BTC Inc., which he co-founded, but hasn’t addressed NAKA’s price action or the late quarterly report.
Market psychology around delays like this is familiar. Investors don’t punish complexity; they punish uncertainty. An acquisition that immediately produces a purchase loss while contingent liabilities move in the company’s favor can be rational in a fast-moving crypto cycle, yet it also raises a simple question: was the integration thesis priced correctly? Until the 10-Q arrives—with final purchase accounting, digital asset fair value details, and debt terms clarified—NAKA likely trades on confidence rather than intrinsic metrics.
For Bitcoin treasury businesses, discipline in deal structure and disclosure can matter as much as coin beta. The filing is a reminder that valuation hygiene and timely reporting are not back-office chores; they are the product itself when the balance sheet is the story.